Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

@article{Tang2008PhaseIS,
  title={Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.},
  author={Colin Tang and D. Andrew Loblaw and Patrick C F Cheung and Lori Holden and Gerald Morton and Parminder S. Basran and Romeo G Tirona and Marlene Cardoso and Geordi Pang and Sandra Gardner and A Cesta},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2008},
  volume={20 10},
  pages={729-37}
}
AIMS Most men with low-risk localised prostate cancer prefer treatments with high control rates and minimal disruption to their lives. Hypofractionating external radiation treatments can theoretically maintain high bioequivalent tumour doses, decrease treatment visits and decrease acute and late toxicities. The aim of this study was to assess the toxicity and feasibility of a hypofractionated accelerated regimen for these patients. MATERIALS AND METHODS The present study was a phase I/II… CONTINUE READING